24
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      CONTRIBUTION OF HPA ACTIVITY AND ENVIRONMENTAL STRESS TO VULNERABILITY FOR SMOKING IN ADOLESCENTS

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Although tobacco smoking, which has been linked to depression, is a major public health problem, little is known about the neurobiological factors that confer vulnerability to smoking in youngsters and the effects of adolescent smoking on the course of depression. This study examined whether hypothalamic-pituitary-adrenal (HPA) activity and stressful life experiences are related to smoking behavior in depressed and non-depressed adolescents, and whether smoking predicts a worsening course of depression. Smoking history and stressful experiences were assessed in 151 adolescents (48 with no personal or family history of psychiatric disorder, 48 with no psychiatric history, but at high-risk for depression by virtue of parental depression, and 55 with current major depressive disorder). Evening salivary cortisol and nocturnal urinary free cortisol were measured for three consecutive evenings. The participants then were followed at regular intervals for up to 5 years to assess smoking history, clinical course of depression and stressful experiences during the follow-up period. Increased evening/night-time cortisol levels were associated with both initiation and persistence of smoking during follow-up. Stressful life experiences further increased the risk for smoking in depressed as well as non-depressed youth. Smoking also was associated with a higher frequency of depressive episodes during follow-up. A model that included stressful experiences and cortisol levels reduced the contribution of smoking per se to depression. High evening/night-time cortisol level appears to be a vulnerability marker for smoking in adolescents, with stressful experiences further increasing the risk for smoking in vulnerable youth. High evening/night-time cortisol levels and stressful experiences accounted, at least partially, for the association between depressive illness and smoking behavior.

          Related collections

          Most cited references132

          • Record: found
          • Abstract: not found
          • Article: not found

          Diagnostic and statistical manual of mental disorders.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.

            In 1988, the MacArthur Foundation Research Network on the Psychobiology of Depression convened a task force to examine the ways in which change points in the course of depressive illness had been described and the extent to which inconsistency in these descriptions might be impeding research on this disorder. We found considerable inconsistency across and even within research reports and concluded that research on depressive illness would be well served by greater consistency in the definition change points in the course of illness. We propose an internally consistent, empirically defined conceptual scheme for the terms remission, recovery, relapse, and recurrence. In addition, we propose tentative operational criteria for each term. Finally, we discuss ways to assess the usefulness of such operational criteria through reanalysis of existing data and the design and conduct of new experiments.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment.

                Bookmark

                Author and article information

                Journal
                8904907
                1376
                Neuropsychopharmacology
                Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
                0893-133X
                1740-634X
                24 July 2009
                19 August 2009
                December 2009
                1 June 2010
                : 34
                : 13
                : 2721-2732
                Affiliations
                [1 ]Department of Psychiatry, UT Southwestern Medical Center, Dallas, TX
                [2 ]Department of Psychology, University of California Los Angeles, Los Angeles, CA
                [3 ]Department of Psychiatry & Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA
                [4 ]Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA
                [5 ]Department of Psychiatry, Meharry Medical College, Nashville, TN, 37208, USA
                Author notes
                Corresponding Author: Uma Rao, M.D., Department of Psychiatry, UT Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9101; TEL: 214-648-5288; FAX: 214-648-5242; uma.rao@ 123456utsouthwestern.edu
                Article
                nihpa133753
                10.1038/npp.2009.112
                2784160
                19693006
                1d81d7b9-5df2-40c6-877a-71e44d829bbb

                Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms

                History
                Funding
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 MH068391-04 ||MH
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 MH068391-03 ||MH
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 MH068391-02 ||MH
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 MH068391-01A1 ||MH
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 MH062464-05 ||MH
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 MH062464-04 ||MH
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 MH062464-03 ||MH
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 MH062464-02 ||MH
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 MH062464-01A1 ||MH
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 DA017805-04S1 ||DA
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 DA017805-04 ||DA
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 DA017805-03 ||DA
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 DA017805-02 ||DA
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 DA017805-01 ||DA
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 DA017804-05 ||DA
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 DA017804-04 ||DA
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 DA017804-03S1 ||DA
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 DA017804-03 ||DA
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 DA017804-02 ||DA
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 DA017804-01 ||DA
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 DA015131-05 ||DA
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 DA015131-04 ||DA
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 DA015131-03 ||DA
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 DA015131-02 ||DA
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 DA015131-01A2 ||DA
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 DA014037-05 ||DA
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 DA014037-04 ||DA
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 DA014037-03 ||DA
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 DA014037-02 ||DA
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 DA014037-01A1 ||DA
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: K08 MH001419-05 ||MH
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: K08 MH001419-04 ||MH
                Categories
                Article

                Pharmacology & Pharmaceutical medicine
                stress,smoking,depression,hpa axis,adolescents,vulnerability
                Pharmacology & Pharmaceutical medicine
                stress, smoking, depression, hpa axis, adolescents, vulnerability

                Comments

                Comment on this article